Post-treatment urinary sarcosine as a predictor of recurrent relapses in patients with prostate cancer-Reference-Cited by-同舟云学术

Post-treatment urinary sarcosine as a predictor of recurrent relapses in patients with prostate cancer

Published:2018-09-12 Issue:11 Volume:7 Page:5411-5419
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Gumulec Jaromir¹^ORCID,Raudenska Martina¹,Pacik Dalibor²³,Plevova Mariana²³,Sorokac-Kubolkova Alena²³,Lackova Zuzana⁴⁵,Cernei Natalia⁵,Strmiska Vladislav⁴,Zitka Ondrej⁴⁵,Heger Zbynek⁴⁵^ORCID,Adam Vojtech⁴⁵^ORCID

Affiliation:

1. Department of Pathological Physiology; Faculty of Medicine; Masaryk University; Brno Czech Republic

2. Department of Urology; University Hospital Brno; Faculty of Medicine; Masaryk University; Brno Czech Republic

3. Faculty of Medicine; Masaryk University; Brno Czech Republic

4. Department of Chemistry and Biochemistry; Mendel University in Brno; Brno Czech Republic

5. Central European Institute of Technology; Brno University of Technology; Brno Czech Republic

Funder

Ministerstvo Školství, Mládeže a Tělovýchovy

Grantová Agentura České Republiky

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.1767/fullpdf

Reference17 articles.

1. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies;Haas;Can J Urol,2008

2. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

3. Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions;Paller;Clin Adv Hematol Oncol,2013

4. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression;Sreekumar;Nature,2009

5. The role of sarcosine metabolism in prostate cancer progression;Khan;Neoplasia,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic signature biomarkers for predicting the recurrence of urological cancers;Clinica Chimica Acta;2023-09

2. Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer;Cellular Oncology;2022-08-29

3. An improved amperometric sarcosine biosensor based on graphene nanoribbon/chitosan nanocomposite for detection of prostate cancer;Sensors International;2022